Literature DB >> 2217023

Loperamide related toxic megacolon in Clostridium difficile colitis.

T Walley, D Milson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2217023      PMCID： PMC2429653          DOI： 10.1136/pgmj.66.777.582-a

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  4 in total

1.  Absence of diarrhea in toxic megacolon complicating Clostridium difficile pseudomembranous colitis.

Authors:  G W Burke; M E Wilson; I O Mehrez
Journal:  Am J Gastroenterol       Date:  1988-03       Impact factor: 10.864

2.  Letter: Adverse effects of Lomotil.

Authors:  F E Pittman
Journal:  Gastroenterology       Date:  1974-08       Impact factor: 22.682

3.  Toxic megacolon--unusual complication of pseudomembranous colitis.

Authors:  T Hoogland; A M Cooperman; R G Farmer; V W Fazio
Journal:  Cleve Clin Q       Date:  1977

4.  Toxic megacolon associated with loperamide therapy.

Authors:  J W Brown
Journal:  JAMA       Date:  1979-02-02       Impact factor: 56.272
  4 in total
  6 in total

Review 1.  Diagnosis and management of Clostridium difficile infection.

Authors:  S Tabaqchali; P Jumaa
Journal:  BMJ       Date:  1995-05-27

2.  Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship.

Authors:  Udayakumar Navaneethan; Preethi Gk Venkatesh; Bo Shen
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

Review 3.  The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Authors:  M Andréjak; J L Schmit; A Tondriaux
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

Review 4.  Adverse effects of drugs used in the management of constipation and diarrhoea.

Authors:  J M Gattuso; M A Kamm
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

5.  COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.

Authors:  Rikke Boedker Holmstroem; Ole Haagen Nielsen; Søren Jacobsen; Lene Buhl Riis; Susann Theile; Jacob Tveiten Bjerrum; Peter Vilmann; Julia Sidenius Johansen; Mogens Karsbøl Boisen; Rikke Helene Løvendahl Eefsen; Inge Marie Svane; Dorte Lisbet Nielsen; Inna Markovna Chen
Journal:  J Immunother Cancer       Date:  2022-09       Impact factor: 12.469

Review 6.  Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management.

Authors:  Mark A Samaan; Polychronis Pavlidis; Sophie Papa; Nick Powell; Peter M Irving
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-03-07       Impact factor: 46.802
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.